Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

The global bird flu treatment market size is estimated to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing outbreaks of avian influenza in the poultry industry and rising awareness about diagnosis among infected patients globally.

Avian influenza is a virus that causes bird flu. It causes sickness in birds, which have the potential to evolve and transmit to people. Depending on the protein found on the virus's surface, bird flu is referred to as H or N. The influenza A, B, and C viruses are the three varieties of influenza viruses. Influenza virus A is classified on the basis of surface proteins hemagglutinin (HA) and neuraminidase. The influenza A virus is further segmented into three categories based on its origin such as avian influenza, swine influenza, and other animal influenza viruses. People are infected with avian influenza through direct contact with contaminated birds. However, avian influenza is a rare disease in humans, it can occur when humans come into close contact with infected birds. A (H5N1) and A (H7N9) are two prevalent viruses that can cause serious illness in humans. Furthermore, the A (H7N9) virus subtype is extremely rare with a low pathogenicity and only found in East Asia. Europe and Africa have had a tremendous impact on many countries, which has resulted in tons of poultry infection and hundreds of human cases of serious disease across geographies.

The COVID-19 pandemic outbreak was an unprecedented global public health crisis that had impacted various industries and its long-term repercussions have had adverse impact on the bird flu treatment market. Furthermore, hospitals and healthcare services were drastically curtailed owing to social distancing measures enacted by governments around the world. Furthermore, the pandemic had a significant impact on the functioning of general hospital treatment for non-COVID-19 patients in hospitals globally.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing precautionary measures especially in the poultry industry to prevent the spread of bird flu is one of the key factors fueling the market growth.
  • Ongoing R&D activities and rising investment by key players to develop improved products with better safety and efficacy are propelling the market growth.
  • Several initiatives undertaken by government bodies in order to increase awareness about disorders among people are offering good opportunities to fuel the growth of the market in the near future.
  • Unhealthy competition among the key players to secure larger market share is expected to hamper the market growth caused by price erosion.
  • Focusing on regenerative drugs and the preference for combination therapy are expected to provide great opportunity for the market growth in the coming years.

 

Key Players

  • AbbVie Inc.
  • Abbott Laboratories
  • Alltech, Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Aurobindo Pharma Ltd.
  • Cipla Ltd.
  • Bristol-Myers Squibb Co.
  • Chewy, Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • F. Hoffmann-La Roche AG
  • Forest Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC.
  • Gilead Sciences Inc.
  • Johnson & Johnson Services, Inc.
  • Merck & Co.
  • Macleods Pharmaceuticals Ltd.
  • Novartis International AG
  • Sinovac Biotech Ltd.
  • Pfizer Inc.
  • Sanofi S.A.

Competitive Landscape

Some of the major players competing in the market are AbbVie Inc.; Abbott Laboratories; Alltech, Inc.; BioCryst Pharmaceuticals, Inc.; Aurobindo Pharma Ltd.; Cipla Ltd.; Bristol-Myers Squibb Co.; Chewy, Inc.; Dr. Reddy’s Laboratories Ltd.; F. Hoffmann-La Roche AG; Forest Pharmaceuticals, Inc.; GlaxoSmithKline PLC.; Gilead Sciences Inc.; Johnson & Johnson Services, Inc.; Merck & Co.; Macleods Pharmaceuticals Ltd.; Novartis International AG; Sinovac Biotech Ltd.; Pfizer Inc.; and Sanofi S.A. These major players are implementing various marketing strategies such as capital investments, merger & acquisitions, and new product development to enhance their market position in the regional as well as global competition.

To Get a New Sample Request: https://growthmarketreports.com/request-sample/2342

 Contact Us

 

 

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe